« Thanks for checking us out | Home | Predicting Recurrence of Prostate Cancer »

Methylation marker for colorectal cancer detection

By admin | April 3, 2006

New data shows that colorectal cancer can be detected early by a free-floating blood test looking for a methylated version of the septin 9 gene. Molecular genomics company Epigonomics AG announced that it has completed a set of studies showing that “presence of the methylated form of DNA encoding the so-called Septin 9 gene is found in plasma of up to 57 percent of patients with all stages of colorectal cancer at high levels of specificity (95%).” The key advance of the screening tool is the ability for patients to screen for colorectal cancer with a blood test rather than with the conventional test requiring submittal of a fecal sample. Link

Related Posts:


  • Epigenomics and Stanford Collaborate on Colorectal Cancer Detection
  • The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.
  • AACR 2007: Epigenomics Improving Colorectal Cancer Detection Success Rate
  • Methylation “suburbs” implicated in colorectal cancer
  • Imprinting Finding May Aid in Colorectal Cancer Screening


  • Topics: cancer, news links |

    Comments are closed.